Related Experiment Videos
Identification and design of binding determinants in proteins
1Department of Biomolecular Chemistry, Genentech, Inc., South San Francisco, CA 94080.
Biochemical Society Symposium
|January 1, 1990
Summary
Mutagenic analysis identified key binding determinants in subtilisin and human growth hormone. Engineering these sites significantly enhanced protein binding affinity, demonstrating a powerful approach for protein design.
Area of Science:
- Protein engineering
- Biochemistry
- Molecular biology
Background:
- Understanding protein-ligand interactions is crucial for drug design and biotechnology.
- Identifying specific binding determinants can be challenging, especially without available structural data.
Purpose of the Study:
- To investigate the use of mutagenic analysis for identifying and engineering protein binding determinants.
- To assess the impact of engineered binding sites on protein-ligand affinity for two distinct proteins.
Main Methods:
- Utilized mutagenic analysis to probe protein binding sites.
- Applied structural models (where available) to guide mutagenesis strategies.
- Assessed changes in binding affinity following protein engineering.
Main Results:
- Successfully identified critical binding determinants in both subtilisin and human growth hormone.
- Engineered binding sites led to substantial increases in binding affinity.
- Demonstrated the feasibility of this approach even without a pre-existing structural model of the complex.
Conclusions:
- Mutagenic analysis is an effective strategy for mapping and engineering protein binding determinants.
- This method can significantly enhance protein-ligand interactions, applicable to enzymes and hormones.
- The approach holds promise for rational protein design and therapeutic development.